SCHEMBL6175309

SCHEMBL6175309

CC(c1c(Cl)cnc2ccccc12)C1(C(C)c2c(Cl)cnc3ccccc23)NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.46
KMT2A Q03164 3/20 0.33
MAPT P10636 2/20 0.33
AR P10275 3/20 0.32
CYP2C9 P11712 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
THRB P10828 1/20 0.32
TP53 P04637 1/20 0.32
CNR1 P21554 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
LMNA P02545 2/20 0.30
MEN1 O00255 1/20 0.30
S1PR4 O95977 1/20 0.30
XBP1 P17861 1/20 0.30
S1PR1 P21453 1/20 0.30
MC4R P32245 1/20 0.30
HTT P42858 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6171811 0.90 IGF1R (0.47) IGF1RKMT2AMAPTARTHRB
SCHEMBL6170972 0.88 IGF1R (0.45) IGF1RKMT2AMAPTARCYP2C9
SCHEMBL6175506 0.88 IGF1R (0.45) IGF1RKMT2AMAPTARTP53
SCHEMBL6176730 0.79 IGF1R (0.46) IGF1RHDAC6CNR1SMN1; SMN2LMNA
SCHEMBL6176726 0.79 IGF1R (0.50) IGF1RKMT2AMAPTARCYP2C9
SCHEMBL6171829 0.78 IGF1R (0.42) IGF1RKMT2AMAPTARCYP2C9
SCHEMBL6173870 0.78 IGF1R (0.43) IGF1RKMT2AMAPTARCYP2C9
SCHEMBL6174716 0.77 KMT2A (0.36) IGF1RKMT2AMAPTARCYP2C9
SCHEMBL6172518 0.76 IGF1R (0.42) IGF1RKMT2AMAPTCYP2C9THRB
SCHEMBL6174619 0.76 IGF1R (0.43) IGF1RKMT2AMAPTARCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed